Understanding the informational needs of patients with IPF and their caregivers: ‘You get diagnosed, and you ask this question right away, what does this mean?’
Abstract:BackgroundIdiopathic pulmonary fibrosis (IPF) is a progressive, incurable lung disease whose intrusive symptoms rob patients of their quality of life. Patients with IPF rely on their caregivers for support and assistance in amounts that vary according to patients’ individual circumstances and disease severity. Knowledgeable and well-informed patients and caregivers are best suited to deal with life-altering conditions like IPF.MethodsWe conducted two hour-long focus groups with 13 patients with IPF and 4 careg… Show more
“…Many participants in this study expressed a desire to know what the future would hold for them. The importance of understanding prognosis, on an individual level rather than a group average, also emerged in our previous qualitative research and that of others . However, it contrasts with another recent qualitative study where many were ambivalent about receiving information about disease progression .…”
Section: Discussionmentioning
confidence: 49%
“…The importance of understanding prognosis, on an individual level rather than a group average, also emerged in our previous qualitative research 16 and that of others. 17 However, it contrasts with another recent qualitative study where many were ambivalent about receiving information about disease progression. 18 Other authors have reported that carers were more likely than patients to seek frank information about prognosis, especially if the patient was deteriorating.…”
Background and objective
New treatments for idiopathic pulmonary fibrosis (IPF) have improved survival; however, the complexity of care may be difficult for patients. The aim of this study was to assess the patient experience of modern IPF care.
Methods
A qualitative study was undertaken for 100 people with IPF with a range of disease severity (forced vital capacity range: 46–106% predicted). Participants were asked about their experience of care using semi‐structured interviews. Two investigators independently undertook analysis using the principles of grounded theory.
Results
Participants reported dissatisfaction with information received about IPF, particularly at the time of diagnosis. Most were enthusiastic about the benefits of specialist IPF centres including regular monitoring, frequent contact with health professionals and access to clinical trials. However, the burden of travel to specialist centres and costs of treatment were significant. Many reported that side effects of anti‐fibrotics caused them to titrate or pause therapy, sometimes without consulting their treating team. Co‐morbid medical conditions had a negative impact on well‐being and highlighted poor coordination of care. Participants perceived a responsibility for self‐management that included exercise, diet, vaccination and treatment of chest infections; many felt this active role should receive more positive emphasis from health professionals.
Conclusion
These data show opportunities to improve modern IPF care including accurate and timely provision of information, improving access to specialist care, more support for managing treatment side effects and better coordination of care for patients with co‐morbid conditions. Future research should explore the impact of self‐management strategies on IPF outcomes.
“…Many participants in this study expressed a desire to know what the future would hold for them. The importance of understanding prognosis, on an individual level rather than a group average, also emerged in our previous qualitative research and that of others . However, it contrasts with another recent qualitative study where many were ambivalent about receiving information about disease progression .…”
Section: Discussionmentioning
confidence: 49%
“…The importance of understanding prognosis, on an individual level rather than a group average, also emerged in our previous qualitative research 16 and that of others. 17 However, it contrasts with another recent qualitative study where many were ambivalent about receiving information about disease progression. 18 Other authors have reported that carers were more likely than patients to seek frank information about prognosis, especially if the patient was deteriorating.…”
Background and objective
New treatments for idiopathic pulmonary fibrosis (IPF) have improved survival; however, the complexity of care may be difficult for patients. The aim of this study was to assess the patient experience of modern IPF care.
Methods
A qualitative study was undertaken for 100 people with IPF with a range of disease severity (forced vital capacity range: 46–106% predicted). Participants were asked about their experience of care using semi‐structured interviews. Two investigators independently undertook analysis using the principles of grounded theory.
Results
Participants reported dissatisfaction with information received about IPF, particularly at the time of diagnosis. Most were enthusiastic about the benefits of specialist IPF centres including regular monitoring, frequent contact with health professionals and access to clinical trials. However, the burden of travel to specialist centres and costs of treatment were significant. Many reported that side effects of anti‐fibrotics caused them to titrate or pause therapy, sometimes without consulting their treating team. Co‐morbid medical conditions had a negative impact on well‐being and highlighted poor coordination of care. Participants perceived a responsibility for self‐management that included exercise, diet, vaccination and treatment of chest infections; many felt this active role should receive more positive emphasis from health professionals.
Conclusion
These data show opportunities to improve modern IPF care including accurate and timely provision of information, improving access to specialist care, more support for managing treatment side effects and better coordination of care for patients with co‐morbid conditions. Future research should explore the impact of self‐management strategies on IPF outcomes.
“…PROMs alone will not lead to improved outcomes without a change in clinicians' approach to care. Ramadurai et al 58 explored the education and information gaps and described both disease-specific as well as individualized content for both patients and caregivers: Education is key because it increases understanding, sense of control, and empowerment. Such information needs to be delivered at the first visit and revisited throughout the course of the disease.…”
Section: Early and Accurate Diagnosis With Patient-centered Educationmentioning
confidence: 99%
“…Poor perceived and worsened QoL (physical, psychosocial, emotional, spiritual, and existential needs) 27,58 Lack of: 1) whole person approach; 2) standardized approach to needs assessment; 3) time to properly assess these needs Provide strategies to preserve QoL Provide anticipatory guidance, use of symptom action plans. Educational resources for patients and caregiver K-BILD, 38 ATAQ-IPFca, 37 SGRQ-IPF, 36 L-IPF, 39 NAT: PD-interstitial lung disease 56 27,75,76 Lack of: 1) PC approach and delayed referral; 2) clinical guidelines; 3) training in sensitive, patient-centered communication Implement end-to-end patient-centered care models Adopt early advanced care planning Provide education and support to the MDT NAT: PD-interstitial lung disease 56 (for palliative care needs), MSAS, 82 MYMOP, 57 L-IPF, 39 K-B interstitial lung disease (to assess QoL and quality of dying), 38 IPF-PREM (to assess care delivery processes) Caregiver distress and increased burden 27 Lack of: 1) understanding of the caregiver needs and engagement; 2) anticipatory guidance;…”
Section: Early and Accurate Diagnosis With Patient-centered Educationmentioning
Idiopathic pulmonary fibrosis is a progressive disease, with a high mortality within the first 3-5 years from diagnosis and a poor quality of life mainly because of the burden of symptoms, such as dyspnea and cough, occurring usually many months before the diagnosis. Although available antifibrotic therapies slow down disease progression, they have no impact on quality of life. Moreover, health care around idiopathic pulmonary fibrosis patients is often "disease-centered" and relies on clinical surrogate outcomes that are poorly related to patients' quality of life and disease experience. Therefore, patients with idiopathic pulmonary fibrosis have several unmet needs in all domains of health that they wish to see recognized and addressed in the context of the treatment of their disease and its complications. In this review, we summarize the care pathway from the patients' perspective, identifying current gaps in care, education, support, and communication among patients with IPF, their caregivers, and care teams during the patient journey. The role of patient-reported outcomes (PROs), PRO measures (PROMs), and patient-reported experience measures (PREMs) in their care is discussed, as well as the need of diseasespecific PROs, PROMs, and PREMs.
“…In an interesting paradox, some caregivers, for the first time in the course of their loved-one’s disease, perceive themselves as truly useful at this transition: instead of just being a ‘nag’, caregivers can give physical care—helping with the logistics of O 2 and taking on more household duties. 9 …”
Patients with idiopathic pulmonary fibrosis (IPF) face a poor prognosis and endure intrusive symptoms that impair quality of life. Many patients with IPF will require supplemental oxygen (O2) at some point in the course of their illness, and although it can improve blood oxygen and symptoms, O2 creates physical and emotional challenges for patients and their loved ones. Four events in the course of IPF—the first occurs at the time of diagnosis and the other three are related to O2—herald periods of transition for patients and their caregivers and mark touchpoints when they need extra care and support from practitioners.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.